Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sjogren's Syndrome 1Scleroderma, Systemic 1Recurrence 1Psoriasis 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Multiple Sclerosis 1Melanoma 1Lymphatic Metastasis 1Lupus Erythematosus, Systemic 1Lung Neoplasms 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Dermatomyositis 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Bronchogenic 1Carcinoma 1Bronchial Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1

Interventions

pembrolizumab 57Nivolumab 50Ipilimumab 31Specimen Handling 23Magnetic Resonance Spectroscopy 19Cyclophosphamide 14Biopsy 11fludarabine 10binimetinib 10Opdualag 10trametinib 9relatlimab 9Radiosurgery 9CTLA-4 Antigen 9dabrafenib 8lifileucel 7fludarabine phosphate 7aldesleukin 7encorafenib 6Interleukin-2 6cemiplimab 5atezolizumab 5Paclitaxel 5Blood Specimen Collection 5X-Rays 4Taxes 4Pemetrexed 4Gemcitabine 4Cisplatin 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Platinum Compounds × 90 days × Clear all
NCT05614102 2026-03-31

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Bayer

Phase 1 Active not recruiting
284 enrolled
DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡